Additionally, the downregulation of NEAT1 induced the expression of N-cadherin and vimentin, but repressed that of E-cadherin, indicating that NEAT1 may inhibit the EMT process in breast cancer cells [34]. This evidence concerns the gene CDH2 and breast carcinoma.